Page last updated: 2024-12-05

granosan mdb

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

granosan MDB: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID10598
SCHEMBL ID163458
MeSH IDM0046092

Synonyms (42)

Synonym
epa pesticide chemical code 041506
n-(ethylmercury)-p-toluenesulphonanilide
mergon
p-toluenesulfonanilide, n-(ethylmercuri)-
zaprawa nasienna universal
ceresan m-db
ethylmercury p-toluene sulfonamide
n-(ethylmercurio)toluene-4-sulphonanilide
mercury, ethyl(4-methyl-n-phenylbenzenesulfonamidato-n)-
ceresan m-2x
mercury, ethyl(n-phenyl-p-toluenesulfonamidato)-
n-ethylmerkuri-p-toluensulfoanilid [czech]
n-(ethylmercuri)-p-toluenesulphonanilide
zaprawa nasienna uniwersalna
zaprawa nasienna universal r
p-toluenesulfonamide, n-(ethylmercuri)-n-phenyl-
ethylmercury p-toluenesulfanilide
benzenesulfono-p-toluidide, n-(ethylmercuri)-
n-(ethylmercuri)-p-toluenesulfonanilide
einecs 208-231-0
granosan mdb
mercury, ethyl(p-toluenesulfonanilidato)-
brn 4153039
mercury, ethyl(n-phenyl-p-toluenesulfonamido)-
n-ethylmercuri-n-phenyl-p-toluenesulfonamide
(n-phenyl-p-toluenesulfonamido)ethylmercury
seed dressing universal
mergon d
ceresan m
caswell no. 453
ethylmercury p-toluenesulfonanilide
ethyl-(n-(4-methylphenyl)sulfonylanilino)mercury
n-ethylmerkuri-p-toluensulfoanilid
mercury, ethyl(4-methyl-n-phenylbenzenesulfonamidato-kappan)-
unii-07tf821rhy
ethylmercury-p-toluene sulfonanilide
517-16-8
SCHEMBL163458
empts
n-ethylmercuri-p-toluenesulfonanilide
DTXSID90895765
Q27236325
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (85.71)18.7374
1990's1 (14.29)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]